Gilligan; Paul J.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Gilligan; Paul J..The latest application filed is for "novel macrocycles as factor xia inhibitors".

Company Profile

0.33.31

Gilligan; Paul J. - Wilmington DE
Gilligan; Paul J - Wilmington DE
Gilligan, Paul J. - US
Gilligan; Paul J. - Claymont DE
Gilligan; Paul J. - New Haven CT

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Dihydropyridone P1 as factor XIa inhibitors Grant 9,951,071 - Yang , et al. April 24, 2	2018-04-24
Macrocycles as factor XIa inhibitors Grant 9,902,742 - Pinto , et al. February 27, 2	2018-02-27
Novel Macrocycles As Factor Xia Inhibitors App 20170158712 - Pinto; Donald J. P. ; et al.	2017-06-08
Macrocycles as factor XIa inhibitors Grant 9,611,274 - Pinto , et al. April 4, 2	2017-04-04
Dihydropyridone P1 As Factor Xia Inhibitors App 20160340360 - Yang; Wu ; et al.	2016-11-24
Dihydropyridone p1 as factor XIa inhibitors Grant 9,409,908 - Yang , et al. August 9, 2	2016-08-09
Dihydropyridone P1 as factor XIa inhibitors Grant 9,376,444 - Yang , et al. June 28, 2	2016-06-28
Novel Macrocycles As Factor Xia Inhibitors App 20160068544 - Pinto; Donald J. P. ; et al.	2016-03-10
Macrocycles as factor XIa inhibitors Grant 9,221,818 - Pinto , et al. December 29, 2	2015-12-29
Cyclic P1 linkers as factor XIa inhibitors Grant 9,108,981 - Lam , et al. August 18, 2	2015-08-18
Dihydropyridone P1 As Factor Xia Inhibitors App 20150203492 - Yang; Wu ; et al.	2015-07-23
Dihydropyridone P1 As Factor Xia Inhibitors App 20150166550 - Yang; Wu ; et al.	2015-06-18
Cyclic P1 Linkers As Factor Xia Inhibitors App 20150057262 - Lam; Patrick Y.S. ; et al.	2015-02-26
Cyclic P1 linkers as factor XIa inhibitors Grant 8,901,115 - Lam , et al. December 2, 2	2014-12-02
Novel Macrocycles As Factor Xia Inhibitors App 20140221338 - Pinto; Donald J. P. ; et al.	2014-08-07
Cyclic P1 Linkers As Factor Xia Inhibitors App 20140163002 - Lam; Patrick Y.S. ; et al.	2014-06-12
Dihydropyridone P1 As Factor Xia Inhibitors App 20140038969 - Yang; Wu ; et al.	2014-02-06
Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor XIa inhibitors Grant 8,604,056 - Pinto , et al. December 10, 2	2013-12-10
Dipeptide analogs as coagulation factor inhibitors Grant 8,367,709 - Pinto , et al. February 5, 2	2013-02-05
Arylpropionamide, Arylacrylamide, Arylpropynamide, Or Arylmethylurea Analogs As Factor Xia Inhibitors App 20120270853 - Pinto; Donald J.P. ; et al.	2012-10-25
Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor XIa inhibitors Grant 8,252,830 - Pinto , et al. August 28, 2	2012-08-28
2-Aryl Glycinamide Derivatives App 20110059940 - Gilligan; Paul J. ; et al.	2011-03-10
Arylpropionamide, Arylacrylamide, Arylpropynamide, Or Arylmethylurea Analogs As Factor Xia Inhibitors App 20110028446 - Pinto; Donald J.P. ; et al.	2011-02-03
Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor XIa inhibitors Grant 7,842,708 - Pinto , et al. November 30, 2	2010-11-30
Dipeptide Analogs As Coagulation Factor Inhibitors App 20100173899 - Pinto; Donald J.P. ; et al.	2010-07-08
4-(2-Butylamino)-2,7-dimethyl-8-(2-methyl-6-methoxypyrid-3-yl)pyrazolo-[1,- 5-A]-1,3,5-triazine, its enantiomers and pharmaceutically acceptable salts as corticotropin releasing factor receptor ligands Grant 7,662,817 - Gilligan February 16, 2	2010-02-16
Arylpropionamide, Arylacrylamide, Arylpropynamide, Or Arylmethylurea Analogs As Factor Xia Inhibitors App 20100022506 - Pinto; Donald J.P. ; et al.	2010-01-28
Arylpropionamide, arylacrylamide, ayrlpropynamide, or arylmethylurea analogs as factor XIa inhibitors Grant 7,626,039 - Pinto , et al. December 1, 2	2009-12-01
Arylpropionamide, Arylacrylamide, Arylpropynamide, Or Arylmethylurea Analogs As Factor Xia Inhibitors App 20080161373 - Pinto; Donald J.P. ; et al.	2008-07-03
4-(2-Butylamino)-2,7-dimethyl-8-(2-methyl-6-methoxypyrid-3-yl)pyrazolo-[1,- 5-A]-1,3,5-triazine, its enantiomers and pharmaceutically acceptable salts as corticotropin releasing factor receptor ligands App 20080139567 - Gilligan; Paul J.	2008-06-12
4-(2-butylamino)-2,7-dimethyl-8-(2-methyl-6-methoxypyrid-3-yl)pyrazolo-[1,- 5-a]-1,3,5-triazine, its enantiomers and pharmaceutically acceptable salts as corticotropin releasing factor receptor ligands Grant 7,358,252 - Gilligan April 15, 2	2008-04-15
Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands Grant 7,319,100 - Arvanitis , et al. January 15, 2	2008-01-15
Substituted Pyrazinones, Pyridines And Pyrimidines As Corticotropin Releasing Factor Ligands App 20070155740 - Arvanitis; Argyrios G. ; et al.	2007-07-05
Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands Grant 7,205,306 - Arvanitis , et al. April 17, 2	2007-04-17
4-(2-Butylamino)-2,7-dimethyl-8-(2-methyl-6-methoxypyrid-3-yl)pyrazolo-[1,- 5-a]-1,3,5-triazine, its enantiomers and pharmaceutically acceptable salts as corticotropin releasing factor receptor ligands App 20070054913 - Gilligan; Paul J.	2007-03-08
4-(2-butylamino)-2, 7-dimethyl-8-(2-methyl-6-methoxypyrid-3-YL) pyrazolo-[1,5-A]-1,3,5-triazine, its enantiomers and pharmaceutically acceptable salts as corticotropin releasing factor receptor ligands Grant 7,157,578 - Gilligan January 2, 2	2007-01-02
Salt and crystalline form thereof of a corticotropin releasing factor receptor antagonist Grant 7,153,961 - Gilligan , et al. December 26, 2	2006-12-26
Sulfonamide bicyclic compounds Grant 7,144,894 - Gilligan December 5, 2	2006-12-05
Pyrazolotriazines as CRF antagonists Grant 7,026,317 - Gilligan , et al. April 11, 2	2006-04-11
Sulfonamide bicyclic compounds App 20060063799 - Gilligan; Paul J.	2006-03-23
Pyrazolotriazines as CRF antagonists Grant 6,960,583 - Gilligan , et al. November 1, 2	2005-11-01
Pyrazolopyrimidines as CRF antagonists Grant 6,958,341 - Wilde , et al. October 25, 2	2005-10-25
Salt and crystalline form thereof of a corticotropin releasing factor receptor antagonist App 20050113375 - Gilligan, Paul J. ; et al.	2005-05-26
Pyrazolotriazines as CRF antagonists App 20040176376 - Gilligan, Paul J. ; et al.	2004-09-09
4- (2-butylamino) -2, 7-dimethyl-8- (2-methyl-6-methoxypyrid-3-YL) pyrazolo- [1,5-A] -1,3,5-triazine, its enantiomers and pharmaceutically acceptable salts as corticotropin releasing factor receptor ligands App 20040014760 - Gilligan, Paul J.	2004-01-22
Imidazo[1, 2-a] pyrazines for the treatment of irritable bowel syndrome App 20030220342 - Bakthavatchalam, Rajagopal ; et al.	2003-11-27
Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands App 20030171380 - Arvanitis, Argyrios G. ; et al.	2003-09-11
Pyrazolopyrimidines as CRF antagonists App 20030139426 - Wilde, Richard G. ; et al.	2003-07-24
Imidazo[1,2-a]pyrazines for the treatment of neurological disorders Grant 6,589,952 - Bakthavatchalam , et al. July 8, 2	2003-07-08
4 - (2-butylamino) - 2, 7-dimethyl-8- (2-methyl-6-methoxypyrid-3-yl) pyrazolo- [1,5-A] - 1,3,5-triazine, its enantiomers and pharmaceutically acceptable salts as corticotropin releasing factor receptor ligands App 20030125330 - Gilligan, Paul J.	2003-07-03
Pyrazolotriazines as CRF antagonists App 20020147338 - Gilligan, Paul J. ; et al.	2002-10-10
Imidazo[1,2-a]pyrazines for the treatment of neurological disorders App 20020049208 - Bakthavatchalam, Rajagopal ; et al.	2002-04-25
Heterocyclyl-substituted ring-fused pyridines and pyrimidines as corticotropin releasing hormone (CRH) antagonists, useful for treating cns and stress-related disorders App 20010025042 - Arvanitis, Argyrios ; et al.	2001-09-27
Nitrogen substituted imidazo[4,5-C]pyrazoles as corticotropin releasing hormone antagonists Grant 6,174,912 - Beck , et al. January 16, 2	2001-01-16
Aryl- and arylamino- substituted heterocycles as corticotropin releasing hormone antagonists Grant 6,103,737 - Cocuzza , et al. August 15, 2	2000-08-15
Antipsychotic nitrogen-containing bicyclic compounds Grant 5,532,243 - Gilligan July 2, 1	1996-07-02
Antipsychotic 1-cycloalkylpiperidines Grant 5,109,002 - Cain , et al. April 28, 1	1992-04-28
Antibiotic derivatives of 7-phenyl-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids Grant 4,623,650 - Gilligan , et al. November 18, 1	1986-11-18

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.